EUVIMEDEUVIMED entdecken
Crossref

Liquid Chromatography Combined With Electrospray Ionization Tandem Mass Spectrometry for the Determination and Identification of AZD5462 and Its Metabolites in Rat Plasma

Congyao You, Yan Zhang, Dece Kong, Tieyi Yang iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Congyao You und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Shanghai University, Shanghai, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Spectrometry, Mass, Electrospray Ionization, Pyrimidines. Die Arbeit nennt 14 Literaturangaben. Gefördert von: Talent Project of Shanghai Pudong New Area, Key Discipline of Health System in Pudong New Area of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AZD5462, a human RXFP1 agonist, which is undergoing clinical development for the treatment of heart failure. The aim of this study was to develop an ultra‐high‐performance liquid chromatography‐tandem mass spectrometric method for the determination of AZD5462 in rat plasma. After precipitated with acetonitrile, the sample was analyzed on a BEH C 18 column using 0.1% formic acid and acetonitrile as mobile phase with a gradient elution at 40°C within 2 min. The assay showed excellent linearity in the range of 0.1–1000 ng/mL with the correlation coefficient more than 0.995. The precision, accuracy, matrix effect, recovery, and stability met all requirements for the quantitation in plasma samples. The validated method has been further applied to the pharmacokinetic study of AZD5462 in rats. In addition, the metabolism of AZD5462 in rat was investigated by a liquid chromatography‐high resolution mass spectrometry. In rat liver microsomes, four metabolites were identified based on their accurate mass and fragment ions. In rat plasma, one glucuronide conjugate was identified. The metabolic pathways of AZD5462 include oxygenation and glucuronidation. This study is the first report on the pharmacokinetics and metabolism of AZD5462, which would provide insights into the effectiveness and toxicity of this drug candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometrySpectrometry, Mass, Electrospray IonizationPyrimidinesAnimalsRatsMaleRats, Sprague-DawleyReproducibility of ResultsChromatography, High Pressure LiquidLinear ModelsLimit of DetectionMicrosomes, LiverBenzimidazolesBiphenyl CompoundsTetrazoles

Stichwörter der Autor:innen

AZD5462RXFP1 agonistbioavailabilitymetabolismpharmacokinetics

Substanzen

flibanserinPyrimidinesfimasartanBenzimidazolesBiphenyl CompoundsTetrazoles

Autor:innen und Institutionen

  • Medical School, Shanghai University, Shanghai, China.
  • Department of Orthopedics, Pudong New Area Gongli Hospital, Shanghai, China.

ORCID-Profile: Tieyi Yang

Förderung

  • Talent Project of Shanghai Pudong New Area
  • Key Discipline of Health System in Pudong New Area of Shanghai

Zitieren

APA

You, C., Zhang, Y., Kong, D., & Yang, T. (2025). Liquid Chromatography Combined With Electrospray Ionization Tandem Mass Spectrometry for the Determination and Identification of AZD5462 and Its Metabolites in Rat Plasma. Biomedical Chromatography. https://doi.org/10.1002/bmc.70095

Vancouver

You C, Zhang Y, Kong D, Yang T. Liquid Chromatography Combined With Electrospray Ionization Tandem Mass Spectrometry for the Determination and Identification of AZD5462 and Its Metabolites in Rat Plasma. Biomedical Chromatography. 2025. doi:10.1002/bmc.70095

BibTeX
@article{You2025,
  author = {You, Congyao and Zhang, Yan and Kong, Dece and Yang, Tieyi},
  title = {Liquid Chromatography Combined With Electrospray Ionization Tandem Mass Spectrometry for the Determination and Identification of AZD5462 and Its Metabolites in Rat Plasma},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70095}
}
Kostenlos starten →